Leukaemia inhibitory factor (LIF) production in pleural effusions: Comparison with production of IL-4, IL-8, IL-10 and macrophage-colony stimulating factor (M-CSF)

Cytokine

Volumn 8, Issue 5, 1996, Pages 410-416

  Heymann, Dominique ^a   L'Her, Erwan ^b   NGuyen, Jean Michel ^b   Raher, Sylvie ^a   Canfrère, Isabelle ^b   Coupey, Lionel ^c   Fixe, Philippe ^b   Chailleux, Edmond ^b   De Groote, Donat ^d   Praloran, Vincent ^c   Godard, Anne ^a  

^a INSTITUT DE BIOLOGIE   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF LIMOGES   (France)

^d Medgenix   (Belgium)

Author keywords

Interleukin; LIF; M CSF; Pleural effusion; Pulmonary disease

Indexed keywords

COLONY STIMULATING FACTOR 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR;

ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PLEURA EFFUSION; PLEURA FLUID; PLEURA TUMOR; PLEURISY; PRIORITY JOURNAL;

EID: 17044452421     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0056     Document Type: Article

References (34)

1. Broaddus VC, Hébert CA, Vitangcol RV, Hoeffel JM, Bernstein MS, Boylan AM (1992) Interleukin-8 is a major neutrophil chemotactic factor in pleural liquid of patients with empyema. Am Rev Respir Dis 1992; 146:825-830.
2. Colotta F, Borre A, Wang JM (1992) Expression of a monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol 148:760-765.
3. Hackett RJ, Davis LS, Lipsky PE (1988) Comparative effects of tumor necrosis factor-α and IL-1β on mitogen-induced T cell activation. J Immunol 140:2639-2644.
4. Paul WE (1991) Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77:1869-1870.
5. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165-190.
6. Praloran V (1991) Structure, biosynthesis and biological roles of monocytic-macrophage colony stimulating factor (CSF-1 or M-CSF). Nouv Rev Fr Hematol 33:323-333.
7. Kelley J (1990) Cytokines of the lung. Am Rev Respir Dis 141:765-788.
8. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM (1992) High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress after trauma, shock, or sepsis. Am Rev Respir Dis 145:1016-1022.
9. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC JR (1992) Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood bronchoalveolar lavage. Am Rev Respir Dis 146:109-115.
10. Yamaguchi E, Okazaki N, Tsuneta Y, Abe S, Terai T, Kawakami Y (1988) Interleukins in pulmonary sarcoidosis. Dissociative correlations of lung interleukins 1 and 2 with the intensity of alveolitis. Am Rev Respir Dis 138:645-651.
11. Moreau JF, Bonneville M, Godard A, Gascan H, Gruart V, Moore MA, Soulillou JP (1987) Characterization of a factor produced by human T cell clones exhibiting eosinophil-activating and burstpromoting activities. J Immunol 138:3844-3849.
12. Godard A, Gascan H, Naulet J, Peyrat MA, Jacques Y, Soulillou JP, Moreau JF (1988) Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 71:1618-1623.
13. Gearing DP, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A, Metcalf D (1987) Molecular cloning and expression of cDNA encoding a murine myeloid leukemia inhibitory factor. Embo J 6:3995-4002.
14. Metcalf D (1991) The leukemia inhibitory factor (LIF). Int J of Cell Cloning 9:95-108.
15. Heymann D, Godard A, Raher S, Ringeard S, Lassort D, Blanchard F, Harb J (1995) Human interleukinfor DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form. Cytokine 7:111-117.
16. Heymann D, Harb J, Ringeard S, Blanchard F, Lassort D, Raher S, Godard A (1995) Upmodulation of αvβ1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and oncostatin M. Correlation with increased cell adhesion on fibronectin. J Cell Biochem 58:305-314.
17. Gascan H, Anegon I, Praloran V, Naulet J, Godard A, Soulillou JP, Jacques Y (1990) Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues. J Immunol 144:2592-2598.
18. Waring P, Wycherley K, Cary D, Nicola N, Metcalf D (1992) Leukemia inhibitory factor levels are elevated in septic shock and various body fluids. J Clin Invest 90:2031-2037.
19. Lecron JC, Roblot P, Chevalier S, Morel F, Alderman E, Gombert J, Gascan H (1993) High circulating Leukaemia Inhibitory Factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under cortosteroid therapy. Clin Exp Immunol 92:23-26.
20. Waring PM, Carroll GJ, Kandiah DA, Buirski G, Metcalf D (1993) Increased levels of leukemia inhibitory factor in synovial fluid from patients with rhumatoid arthritides. Arthritis Rheum 36:911-915.
21. Villers D, Dao T, NGuyen JM, Bironneau E, Godard A, Moreau M, De Groote D, Nicolas F, Soulillou JP, Anegon I (1995) Increased plasma levels of HILDA/LIF in sepsis correlated with shock and poor diagnosis. J Infect Disease 171:232-236.
22. Praloran V, Raventos-Svarez C, Bartocci A, Lucas J, Stanley ER, Gibbons JJ (1990) Alterations in the expression of colony stimulating factor-1 and its receptor during an acute graft-vs-host reaction in mice. J Immunol 145:3256-3261.
23. Anegon I, Moreau JF, Godard A, Jacques Y, Peyrat MA, Hallet MM, Wong G, Soulillou JP (1990) Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol 130:50-65.
24. Miyagy T, Akashi M, Yamato K, Miyoshi I, Koeffler HP (1991) D factor: modulation of expression in fibroblasts. Leukemia Research 15:441-451.
25. Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15:74-88.
26. Arend WP, Dayer JM (1990) Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33:305-315.
27. Marchant A, Devière J, Baudouin B, De Groote D, Vincent JL, Goldman M (1994) Interleukin-10 production during septicaemia. Lancet 343:707-708.
28. Antony VB, Godbey SW, Kunkel, SL, Hott JW, Hartman DL, Burdick MD, Stricter RM (1993) Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol 151:7216-7223.
29. Stephens KE, Ishizaka A, Larrick JW, Raffin TA (1988) Tumor Necrosis Factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. Am Rev Respi Dis 137:1363-1370.
30. Collins TR, Sahn SA ( 1987) Thoracocentesis: clinical value, complications, technical problems and patient experience. Chest 91:817-822.
31. De Groote D, Fauchet F, Jadoul M, Dehart I, Raher S, Gevaert Y, Lopez M, Gathy R, Franssen JD, Radou D, Franchimont P, Soulillou JP, Jacques, Godard A (1994) An ELISA for the measurement of human leukemia inhibitory factor in biological fluids and culture supernatants. J Immunol Methods 167:253-261.
32. Chretien I, van Kimmenade A, Pearce MK, Banchereau J, Abrams JS (1989) D evelopment of a polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin-4. J Immunol Methods 117:67-81.
33. Ko YC, Mukaida N, Panyutich A, Voitenok NN, Matsushima K, Kawai T, Kasahara T (1992) Establishment of a sensitive enzyme-linked immunosorbent assay for human IL-8. J Immunol Methods 149:227-235.
34. Mire-Sluis AR, Gaines Das R, Thorpe R (1995) Participants of the collaborative study: The international standard for macrophage-colony stimulating factor (M-CSF). Evaluation in an international collaborative study. J Immunol Methods 179:141-151.